A detailed history of Aviso Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Aviso Wealth Management holds 2,014 shares of LLY stock, worth $1.51 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
2,014
Previous 2,139 5.84%
Holding current value
$1.51 Million
Previous $1.94 Billion 7.83%
% of portfolio
0.97%
Previous 1.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $96,517 - $120,002
-125 Reduced 5.84%
2,014 $1.78 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $57,264 - $71,814
79 Added 3.83%
2,139 $1.94 Billion
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $82,315 - $110,126
139 Added 7.24%
2,060 $1.6 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1.01 Million - $1.19 Million
1,921 New
1,921 $1.12 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aviso Wealth Management Portfolio

Follow Aviso Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviso Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aviso Wealth Management with notifications on news.